AAllocator DeskDiligence Memory

All Templates

Template

Continuation Vehicle Due Diligence Questions

A structured question set for LPs deciding to roll, sell, or commit new money in a continuation vehicle.

What this template is for

GP-led continuation vehicles compress a complex decision into a short window. Existing LPs must decide whether to roll, sell, or make a partial election, while new investors must underwrite the asset or assets at a fresh price with a new fee, carry, and governance structure. This template provides the questions LPs should answer before making an election or committing new money.

When LP teams use it

  • GP-led single-asset continuation vehicle
  • GP-led multi-asset continuation vehicle
  • Strip sale or tender offer
  • Continuation vehicle with new-money follow-on capital
  • Continuation vehicle involving a fund nearing end of term
  • Post-decision review of a CV transaction
  • IC preparation for a roll, sell, partial sale, or new-money decision

The template

Transaction overview

  • GP name and original fund
  • Continuation vehicle name
  • Single-asset, multi-asset, or strip transaction
  • Asset or assets included
  • Existing LP election options: roll / sell / partial roll / partial sale
  • New-money opportunity offered
  • Election deadline and expected closing date
  • Lead buyer or syndicate composition
  • Financial advisor, legal counsel, fairness opinion provider
  • LPAC involvement
  • Recommended status: roll / sell / partial / commit new money / decline new money / defer

Why this transaction exists

  • Why the GP is pursuing a CV instead of a sale, IPO, recap, or hold inside the existing fund
  • Is the original fund near the end of term
  • Is the GP seeking more time for value creation
  • Is the GP solving a liquidity need for existing LPs
  • Is the GP solving a fundraising, DPI, or track record issue
  • Is the GP raising additional capital for the asset
  • Is the transaction driven by one asset, several assets, or fund-level pressure
  • What alternatives the GP evaluated
  • What would happen if the CV transaction did not close
  • Does the rationale benefit existing LPs, the GP, new investors, or all parties

Transaction structure

  • Single-asset, multi-asset, or strip
  • Existing LPs: roll, sell, or partial elections
  • Minimum and maximum rollover amount
  • New-money pricing and terms
  • Lead buyer or syndicate composition
  • Secondary buyer identity and reputation
  • New investor rights
  • Governance structure of the CV
  • Expected ownership after transaction
  • Use of proceeds
  • Follow-on capital needs
  • Debt financing or refinancing involved
  • Management and GP rollover
  • Treatment of existing fund reserves
  • Treatment of unfunded commitments
  • Any stapled primary commitment or related fundraising arrangement
  • Any related-party transaction or affiliate involvement

Fairness, process, and conflicts

  • Fairness opinion provider and scope
  • Was a third-party valuation obtained
  • Auction, limited auction, or bilateral process
  • Number and type of bidders contacted
  • Number of bids received
  • Was there a market check
  • Why the lead buyer was selected
  • LPAC involvement and recommendation
  • Were conflicts disclosed clearly
  • Did the GP disclose its economic incentives
  • Was the election timeline reasonable
  • Were LPs given enough information to evaluate the transaction
  • Was the process designed to maximize price, provide liquidity, retain upside, or balance all three
  • Did the GP or advisor create any pressure to roll
  • Are selling LPs and rolling LPs treated fairly
  • Are new-money investors receiving rights that rolling LPs do not receive

Fees, carry, and economics reset

  • Management fee in the CV and basis
  • Carry rate, preferred return, and catch-up
  • GP carry crystallization at transaction close
  • Amount of crystallized carry
  • GP rollover of crystallized carry
  • GP cash-out amount, if any
  • New GP commitment
  • Fee holiday or reduced-fee period
  • Transaction expenses paid by existing LPs, rolling LPs, new LPs, or the asset
  • Treatment of broken-deal expenses
  • Comparison to economics in the original fund
  • Does the fee/carry reset fairly reflect remaining work and risk
  • What economics the GP earns if the asset merely reaches the base case

Asset-level diligence

  • Asset performance since original investment
  • Original investment thesis
  • Current business plan and updated value-creation thesis
  • Historical revenue, EBITDA, cash flow, or operating performance
  • Performance vs. original underwriting case
  • Key drivers of value creation to date
  • Remaining value creation plan
  • Management team quality and alignment
  • Customer, tenant, borrower, or counterparty concentration
  • Capex or follow-on capital requirements
  • Debt and capital structure; covenants and maturity schedule
  • Recent trading, operating, or valuation trends
  • Reason for not exiting via traditional sale, IPO, or recapitalization
  • Comparable transaction support for pricing
  • Third-party diligence materials reviewed
  • What has to be true for the asset to generate the target return from today's price

Pricing and valuation

  • Transaction valuation
  • Entry multiple or valuation basis
  • Price vs. last reported NAV and prior internal marks
  • Discount or premium to NAV
  • Comparable company and transaction support
  • DCF, exit multiple, growth, margin, and debt paydown assumptions
  • Sensitivity to exit multiple, growth, rates, and margin
  • Valuation advisor opinion, if any
  • Price discovery quality
  • Does the price compensate rolling LPs for the risk of staying in
  • Does the price compensate new-money investors for underwriting at today's value

Alignment

  • GP commitment and rollover into CV
  • GP cash-out vs. rollover
  • Carry crystallization vs. rollover
  • Management rollover and reinvestment
  • Lead buyer alignment
  • Other LP elections, if known
  • Signal from sophisticated LPs
  • Is the GP's upside aligned with rolling LPs
  • Is the GP's downside meaningful
  • Does the GP have enough capital at risk after closing
  • Do new investors have better rights or economics than rolling LPs
  • Do selling LPs influence the process in a way that disadvantages rolling LPs

Roll decision framework

  • Do we have enough information to underwrite the asset at the CV price
  • Is the asset still consistent with our original reason for investing
  • Do we believe the remaining value creation plan
  • Are we comfortable with the new fee and carry structure
  • Are we comfortable with the governance rights
  • Are we comfortable with the expected hold period
  • What is the opportunity cost of rolling
  • What portfolio concentration does rolling create
  • What liquidity are we giving up by rolling
  • What would make us regret rolling
  • If this were offered as a new deal today, would we invest

Sell decision framework

  • Are we comfortable with the price discovery
  • Does selling lock in an acceptable return
  • Does selling improve liquidity, pacing, or concentration
  • Are we selling because of asset, GP, portfolio, or process concerns
  • What upside are we giving up
  • What downside are we avoiding
  • Could a sale harm the GP relationship
  • Would we sell a partial amount instead of the full position
  • How does the sale compare to other liquidity options
  • What would make us regret selling

New-money decision framework

  • Are we underwriting this as a new investment rather than a relationship accommodation
  • What is the alternative use of capital
  • Is the expected return attractive from today's price
  • Are we receiving appropriate economics and rights
  • Are we comfortable with information quality
  • Are we comfortable with sponsor alignment
  • Does the asset fit our current portfolio
  • Does the transaction increase concentration with the GP, sector, vintage, or asset
  • Would we commit if we were not already an LP in the GP's fund
  • What conditions would need to be met before committing new money

Liquidity, tax, and portfolio implications

  • Liquidity impact of rolling vs. selling
  • Pacing and vintage-year exposure impact
  • GP, sector, and asset concentration impact
  • Remaining hold period
  • Expected distribution timing
  • Tax consequences of sale or rollover
  • UBTI, ECI, withholding, or blocker considerations
  • K-1 or reporting implications
  • ERISA or policy considerations, if applicable
  • Accounting or valuation implications
  • Does the transaction create any policy or mandate issue

Legal and governance terms

  • CV LPA and election documents reviewed
  • Side letter available
  • Information, reporting, LPAC, consent, and removal rights
  • Key-person provisions
  • Transfer, exit, MFN, and co-investment rights
  • Confidentiality provisions
  • Most important legal differences vs. original fund
  • Open legal issues before election
  • Counsel and tax reviewer

Timeline and process discipline

  • Date materials received and data room opened
  • Election deadline and IC date
  • Legal and tax review deadlines
  • Sponsor, management, advisor, and LPAC calls completed
  • Additional materials requested
  • Materials still outstanding
  • Decision owner and current blocker
  • Can we complete enough diligence before the deadline
  • If not, what is the default decision and why

Post-decision record

  • Election made: roll / sell / partial roll / partial sale / commit new money / decline new money
  • Election amount
  • Rationale for decision
  • Primary reason for not choosing the alternative
  • Conditions or asks made of the GP
  • Open items at election
  • IC decision and vote record, if applicable
  • Dissenting or abstaining views
  • Lessons captured for future CV decisions
  • Items to add to ongoing manager monitoring
  • Items to add to side letter or obligations tracker
  • Next review date
  • Link to final memo and source documents

Post-close monitoring plan

  • Reporting cadence
  • Information rights confirmed
  • Expected hold period
  • Key value-creation milestones
  • Operating, debt or refinancing, and exit milestones to monitor
  • Follow-on capital needs
  • GP contact and internal owner
  • Escalation triggers
  • When we should revisit the roll/sell decision
  • How we will compare actual outcome to the CV underwriting case

Common mistakes

  • Defaulting to roll because the process is fast
  • Treating the fairness opinion as the diligence
  • Failing to capture other LP elections as signal
  • Not asking why a traditional exit was not pursued
  • Ignoring fee and carry reset economics
  • Failing to separate GP liquidity motives from asset-level rationale
  • Underwriting the asset based on old fund marks rather than today's price
  • Not comparing roll, sell, partial sale, and new-money alternatives side by side
  • Treating new money as a relationship decision rather than a fresh underwriting decision
  • No record of the decision rationale for future review
  • No post-close monitoring plan against the CV underwriting case

How Allocator Desk manages this in a live system

  • Creates a continuation vehicle decision workflow with process, fairness, conflicts, alignment, pricing, and election fields
  • Captures roll, sell, partial, and new-money rationale in the decision journal
  • Links CV materials, LPAC notes, sponsor calls, legal review, tax review, IC memos, and prior GP coverage into one record
  • Surfaces patterns across CV transactions by GP, sector, vintage, process quality, and decision outcome
  • Tracks post-close monitoring against the underwriting case and original election rationale
  • Connects CV decisions to the GP's overall coverage, re-up record, side letter obligations, and portfolio concentration view
  • Turns continuation vehicle elections from rushed one-off decisions into a searchable record of process quality, alignment, and LP judgment